Andrea Tompa

Senior Lecturer Biomedical Laboratory Science
Department of Clinical Diagnostics , School of Health and Welfare
Ph.D.

Contact

Room
Ga1030
Telephone
SMS-number
+46 79-068 92 47
Change your information

Research groups

Boards, committees etc.

Article

Fryk, E., Wilsson, Å., Tompa, A., Jansson, P., Faresjö, M. (2024). Galectin-1 correlates with inflammatory markers and T regulatory cells in children with type 1 diabetes and/or celiac disease Clinical and Experimental Immunology, 215(3), 240-250. More information
Tompa, A., Faresjö, M. (2024). Shift in the B-cell subsets between children with type 1 diabetes and/or celiac disease Clinical and Experimental Immunology, 216(1), 36-44. More information
Tompa, A., Johansson, J., Islander, U., Faresjoe, M. (2024). Flow Cytometric Immunophenotyping: Minimal Differences in Fresh and Cryopreserved Peripheral Blood Mononuclear Cells versus Whole Blood Biomedicines, 12(10). More information
Tompa, A., Åkesson, K., Karlsson, S., Faresjö, M. (2020). Suppressed immune profile in children with combined type 1 diabetes and celiac disease Clinical and Experimental Immunology, 201(3), 244-257. More information
Tompa, A., Nilsson-Bowers, A., Faresjö, M. (2018). Subsets of CD4+, CD8+, and CD25hi Lymphocytes Are in General Not Influenced by Isolation and Long-Term Cryopreservation Journal of Immunology, 201(6), 1799-1809. More information
Carlsson, E., Magnusson, A., Tompa, A., Bülow, P., Gerdner, A., Faresjö, M. (2016). Psychological stress affects the numbers of circulating CD56+CD16+ and CD4+CD25+FoxP3+CD127- cells and induce an immune response towards type 1 diabetes-related autoantigens in young women . More information
Åkesson, K., Tompa, A., Rydén, A., Faresjö, M. (2015). Low expression of CD39+/CD45RA+ on regulatory T cells (Treg) cells in type 1 diabetic children in contrast to high expression of CD101+/CD129+ on Treg cells in children with coeliac disease Clinical and Experimental Immunology, 180(1), 70-82. More information
Cherfan, P., Tompa, A., Wikby, A., Löfgren, S., Jonasson, L. (2007). Effects of simvastatin on human T cells in vivo Atherosclerosis, 193(1), 186-192. More information
Nijm, J., Wikby, A., Tompa, A., Olsson, A., Jonasson, L. (2005). Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. American Journal of Cardiology, 95(4), 452-456. More information
Jonasson, L., Tompa, A., Wikby, A. (2003). Expansion of peripheral CD8+ T cells in patients with coronary artery disease: relation to cytomegalovirus infection. Journal of Internal Medicine, 254(5), 472-478. More information
Hyland, P. Duggan, O. Turbitt, J. Coulter, J. Wikby, A. Johansson, B. , ... Barnett Y. (2002). Nonagenarians from the Swedish NONA Immune Study have increased plasma antioxidant capacity and similar levels of DNA damage in peripheral blood mononuclear cells compared to younger control subjects Experimental Gerontology, 37(2-3), 465-473. More information
Ross, O. Hyland, P. Curran, M. McIlhatton, B. Wikby, A. Johansson, B. , ... Barnett Y. (2002). Mitochondrial DNA damage in lymphocytes: a role in immunosenescence? Experimental Gerontology, 37(2-3), 329-340. More information

Doctoral thesis

Tompa, A. (2021). Pinpointing biomarkers of importance for children with combined type 1 diabetes and celiac disease (Doctoral thesis, Jönköping: Jönköping University, School of Health and Welfare). More information

Conference paper

Tompa, A., Åkesson, K., Karlsson, S., Faresjö, M. (2019). Suppressed immune profile in children with type 1 diabetes in combination with celiac disease. ESCCA 2019, Flowrescence in the Fjords, Bergen, Norway, 18-21 September 2019. More information
Tompa, A. (2018). Subsets of CD4+, CD8+ and CD25hi lymphocytes are in general not influenced by isolation and long-term cryopreservation. ESCCA 2018 Conference: At the Shore of Future Cytometry, September 13–15, 2018, Valencia, Spain. More information

Other publications

Tompa, A., Faresjö, M. . Characterization of B cell subsets in children with type 1 diabetes and/or celiac disease. More information